TET2 mutations frequently occur in AITL (47%-83%), with nonsense and frameshift mutations spread over the whole TET2 protein, yet missense mutations are restricted to the C-terminal catalytic domain (17). This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.